Global Prostate Cancer Devices Market Report In-depth Analysis , Segmentation, Revenue, Geographical Presence Expected to Grow at CAGR 13.48% and Forecast to 2019

Prostate Cancer Devices
        Scope of the Report: 
1)    About this Report
Prostate cancer is one of the most common cancer in men. It occurs in the prostate gland, a small walnut-shaped gland. The primary function of the prostate gland is to produce seminal fluid that nourishes and transports sperm. The occurrence of prostate cancer is age dependent and typically occurs in men aged 65 years and more. This disease exhibits no early symptoms, and most prostate cancers are slow growing. Prostate cancer treatment includes chemotherapy, surgery, cryotherapy, and hormonal/radiation therapy. 
2)     Analysis of this report
Technavio's analysts forecast the global prostate cancer devices market to grow at a CAGR of 13.48% over the period 2014-2019.
3)     Covered in this Report
This report covers the present scenario and the growth prospects of the global prostate cancer devices market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of prostate cancer devices based on their applications.
Types of applications:
• External beam radiation therapy
• Radical prostatectomy
• Brachytherapy
• Cryotherapy
• HIFU
The report includes revenue generated from the following regions: Americas, APAC, and EMEA. It presents the vendor landscape and a corresponding detailed analysis of the top six vendors in the market. The vendor landscape in this report focuses on those vendors that provide access to new prostate cancer devices.
Technavio's report, Global Prostate Cancer Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• C. R. Bard
• Elekta
• Intuitive Surgical
• Siemens Healthcare
• Theragenics
• Varian Medical Systems
Other Prominent Vendors
• Eckert & Ziegler BEBIG
• EDAP TMS
• Galil Medical
• IsoRay
• Philips Healthcare
• Profound Medical
• SonaCare Medical
Market Driver
• Increase in Aging Population
• For a full, detailed list, view our report
Market Challenge
• Complications of Prostate Cancer Surgeries
• For a full, detailed list, view our report
Market Trend
• Adoption of Robotic Prostatectomy
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?



Key Regions
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report

    03.1 Market Overview
    03.2 Product Offerings
04. Market Research Methodology
    04.1 Market Research Process
    04.2 Research Methodology
05. Introduction
06. Market Landscape
    06.1 Market Overview
    06.2 Market Size and Forecast
    06.3 Five Forces Analysis
07. Overview: Prostate Cancer
    07.1 Complications
    07.2 Treatment
08. Market Segmentation by Type of Application
      08.1.1 Brachytherapy
      08.1.2 Radical Prostatectomy
      08.1.3 Cryotherapy
      08.1.4 HIFU
      08.1.5 External Beam Radiation Therapy
    08.2 Global External Beam Radiation Therapy Market
      08.2.1 Market Size and Forecast
    08.3 Global Radical Prostatectomy Market
      08.3.1 Market Size and Forecast
    08.4 Global Brachytherapy Market
      08.4.1 Market Size and Forecast
    08.5 Global Cryotherapy Market
      08.5.1 Market Size and Forecast
    08.6 Global HIFU Market
      08.6.1 Market Size and Forecast
09. Geographical Segmentation
    09.1 Global Prostate Cancer Devices Market Segmentation by Geography 2014-2019
    09.2 Prostate Cancer Devices Market in Americas
      09.2.1 Market Size and Forecast
    09.3 Prostate Cancer Devices Market in EMEA
      09.3.1 Market Size and Forecast
    09.4 Prostate Cancer Devices Market in APAC
      09.4.1 Market Size and Forecast
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
    17.1 Competitive Scenario
      17.1.1 Key News
      17.1.2 Mergers and Acquisitions
    17.2 Market Share Analysis 2014
    17.3 Other Prominent Vendors
18. Key Vendor Analysis
    18.1 C. R. Bard
      18.1.1 Key Facts
      18.1.2 Business Overview
      18.1.3 Product Segmentation by Revenue 2013
      18.1.4 Product Segmentation by Revenue 2012 and 2013
      18.1.5 Geographical Segmentation by Revenue 2013
      18.1.6 Business Strategy
      18.1.7 Recent Developments
      18.1.8 SWOT Analysis
    18.2 Elekta AB
      18.2.1 Key Facts
      18.2.2 Business Description
      18.2.3 Product Categorization
      18.2.4 Revenue Segmentation by Product Offerings
      18.2.5 Revenue Comparison across Geographies
      18.2.6 Sales by Geographical Segmentation
      18.2.7 Business Strategy
      18.2.8 Key Developments
      18.2.9 SWOT Analysis
    18.3 Intuitive Surgical
      18.3.1 Key Facts
      18.3.2 Business Overview
      18.3.3 Segmentation by Revenue 2014
      18.3.4 Segmentation by Revenue 2013 and 2014
      18.3.5 Geographical Segmentation by Revenue 2014
      18.3.6 Business Strategy
      18.3.7 Recent Developments
      18.3.8 SWOT Analysis
    18.4 Siemens Healthcare
      18.4.1 Key Facts
      18.4.2 Business Overview
      18.4.3 Product Segmentation
      18.4.4 Geographical Segmentation by Revenue 2013
      18.4.5 Business Strategy
      18.4.6 Recent Developments
      18.4.7 SWOT Analysis
    18.5 Theragenics
      18.5.1 Key Facts
      18.5.2 Business Overview
      18.5.3 Business Segmentation
      18.5.4 End-markets
      18.5.5 Recent Developments
      18.5.6 SWOT Analysis
    18.6 Varian Medical Systems
      18.6.1 Key Facts
      18.6.2 Business Description
      18.6.3 Business Segmentation
      18.6.4 Revenue Segmentation by Business
      18.6.5 Segmental Revenue Comparison - 2013 and 2012
      18.6.6 Sales by Geographical Segmentation
      18.6.7 Business Strategy
      18.6.8 Key Developments
      18.6.9 SWOT Analysis
19. Other Report in this Serie



Table of Content

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report

    01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
    03.1 Market Overview
    03.2 Product Offerings
04. Market Research Methodology
    04.1 Market Research Process
    04.2 Research Methodology
05. Product Profiles
    05.1 Paxil/Seroxat
    05.2 Zoloft
06. Introduction
07. PTSD Overview
    07.1 Understanding the Disorder
    07.2 Etiology and Pathogenesis
    07.3 Signs and Symptoms
      07.3.1 Re-experiencing Symptoms
      07.3.2 Avoidance Symptoms
      07.3.3 Arousal Symptoms
    07.4 Diagnosis
    07.5 Management
      07.5.1 Psychotherapy
      07.5.2 Pharmacotherapy
    07.6 Self-Help Treatment of PTSD
    07.7 Epidemiology
    07.8 Economic Burden
08. Pipeline Analysis
    08.1 Information on Pipeline Candidates
      08.1.1 Brexpiprazole
      08.1.2 Iloperidone
      08.1.3 NBI-77860/GSK-561679
      08.1.4 At-Ease
      08.1.5 PRX-3140
      08.1.6 SNC-102
      08.1.7 TNX-102 SL
      08.1.8 Ganaxolone
      08.1.9 SRX251 and SRX246
      08.1.10 Doxazosin
      08.1.11 pep-EphrinA4
09. Market Landscape
    09.1 Market Overview
    09.2 Market Size and Forecast
    09.3 Five Forces Analysis
10. Market Segmentation by Class of Drug
    10.1 Antidepressant Drugs
      10.1.1 SSRIs
      10.1.2 SNRIs
      10.1.3 Tricyclic Antidepressants
      10.1.4 MAO Inhibitors
    10.2 Anti-anxiety Drugs
      10.2.1 Benzodiazepines
      10.2.2 Beta-blockers
    10.3 Others
      10.3.1 Atypical Antipsychotics
      10.3.2 Anticonvulsants
      10.3.3 Alpha-1 Receptor Antagonists
      10.3.4 Alpha-2 Adrenergic Agonists
11. Geographical Segmentation
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and Their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and Their Impact
19. Vendor Landscape
    19.1 Competitive Scenario
      19.1.1 Key News
      19.1.2 Mergers and Acquisitions
    19.2 Market Analysis 2014
      19.2.1 Pfizer
      19.2.2 GlaxoSmithKline
      19.2.3 Otsuka Pharmaceutical
    19.3 Other and Future Prominent Vendors
20. Global PTSD Therapeutics Market: Key Takeaways
21. Key Vendor Analysis
    21.1 GlaxoSmithKline
      21.1.1 Key Facts
      21.1.2 Business Overview
      21.1.3 Business Segmentation by Revenue 2014
      21.1.4 Business Segmentation by Revenue 2013 and 2014
      21.1.5 Geographical Segmentation by Revenue 2014
      21.1.6 Business Strategy
      21.1.7 Recent Developments
      21.1.8 SWOT Analysis
    21.2 Otsuka Pharmaceutical
      21.2.1 Key Facts
      21.2.2 Business Overview
      21.2.3 Business Segmentation by Revenue 2014
      21.2.4 Business Segmentation by Revenue 2013 and 2014
      21.2.5 Geographical Segmentation by Revenue 2014
      21.2.6 Business Strategy
      21.2.7 Recent Developments
      21.2.8 SWOT Analysis
    21.3 Pfizer
      21.3.1 Key Facts
      21.3.2 Business Overview
      21.3.3 Business Segmentation by Revenue 2014
      21.3.4 Business Segmentation by Revenue 2013 and 2014
      21.3.5 Geographical Segmentation by Revenue 2014
      21.3.6 Business Strategy
      21.3.7 Key Developments
      21.3.8 SWOT Analysis
22. Other Reports in This Series 
            Continued……………
Visit to our official website on Linkedin@ https://goo.gl/CQPn5j
Continued………………….

CONTACT US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)











Comments